FDA Announces Approval of Information Collection for Unapproved/New Uses of Marketed Drugs, Biologics, and Devices

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on the dissemination of data about unapproved or new uses for marketed drugs, biologics, and devices, as required by the Paperwork Reduction Act of 1995.